OralBiotic™ - 60 Lozenges
Item#: 2921
Manufacturer SKU: 733739029218
- BLIS K12®
- Supports Mouth and Throat Health
- Reduces Bad Breath*
- A Dietary Supplement
NOW® OralBiotic™ contains the naturally occurring probiotic organism Streptococcus salivarius BLIS K12®, which has been clinically shown to support oral and throat health. Although it is not an antibiotic, OralBiotic™ BLIS K12® successfully colonizes the oral cavity at the expense of other bacteria, promoting oral health. It also helps to improve breath when used in conjunction with proper oral hygiene. Fructooligosaccharides (FOS) provide nutritional support for S. salivarius.*
Suggested Usage
As a dietary supplement, take 1 lozenge 1 to 4 times daily. Allow lozenge to dissolve slowly and completely in mouth and swallow. Consider taking this product in combination with NOW® Probiotic-10™, Olive Leaf Extract and XyliWhite™ Mouthwash.
Consider taking these other NOW® products:Related Links
| Serving Size: | 1 Lozenge | ||
|---|---|---|---|
| Servings Per Container: | 60 | ||
| Amount Per Serving | % Daily Value* | ||
|
* Percent Daily Values are based on 2,000 calorie diet. † Daily Value not established. |
|||
| BLIS K12® Streptococcus salivarius | 1 Billion cfu | * | |
Other Ingredients: FOS (Fructooligosaccharides), Xylitol, Sorbitol, Cellulose, Silica, Stearic Acid (vegetable source), Natural Strawberry Flavor, Beet Powder and Natural Vanilla Flavor. Contains milk derivative.
Refrigerate after opening to maintain high potency.
Contains no: salt, wheat, gluten, soy, egg, shellfish or preservatives.
Do Not Eat Freshness Packet. Keep in Bottle.
This product is formulated with 2 Billion Bacteria at time of manufacture. Keep refrigerated to maintain live bacteria counts.
BLIS K12® and the BLIS K12® logo are registered trademark of BLIS Technologies.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This information current as of 3/11/13 3:45 PM.


Extracts





E-Newsletter sign-up
Facebook
Twitter